APA (7th ed.) Citation

WS, B., KF, D., NJ, A., H, Z., O, H., JJV, M., & K, B. (2024). Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial. JAMA neurology, 81(2), 197. https://doi.org/10.1001/jamaneurol.2023.4719

Chicago Style (17th ed.) Citation

WS, Brum, Docherty KF, Ashton NJ, Zetterberg H, Hansson O, McMurray JJV, and Blennow K. "Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial." JAMA Neurology 81, no. 2 (2024): 197. https://doi.org/10.1001/jamaneurol.2023.4719.

MLA (9th ed.) Citation

WS, Brum, et al. "Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial." JAMA Neurology, vol. 81, no. 2, 2024, p. 197, https://doi.org/10.1001/jamaneurol.2023.4719.